HTBX Insider Trading Activity and SEC Form 4 Filings
HTBX insider trading summary
No open-market insider purchases or sales of Heat Biologics, Inc. (HTBX) have been reported on SEC Form 4 in the past 12 months.
Latest HTBX insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| May 14, 2021 | John K A Prendergast | Director | Sell | $205K (35,000 @ $5.87) |
| Nov 12, 2020 | Edward B Smith III | Director | Sell | $106K (103,304 @ $1.03) |
| Mar 23, 2016 | Michael Kharitonov | Director | Buy | $675K (900,000 @ $0.75) |
| Jun 5, 2014 | Melissa Price | VP Clinical/Regulatory Affairs | Buy | $1K (346 @ $4.30) |
| Jun 5, 2014 | Melissa Price | VP Clinical/Regulatory Affairs | Buy | $1K (346 @ $4.30) |
| May 19, 2014 | Orion Holdings V, LLC | 10% Owner | Buy | $1K (346 @ $4.10) |
| May 19, 2014 | Seed-One Holdings VI, LLC | 10% Owner | Buy | $1K (346 @ $4.10) |
| May 19, 2014 | Jeffrey Alan Wolf | Chief Executive Officer | Buy | $7K (1,754 @ $4.15) |
| May 19, 2014 | Seed-One Holdings VI, LLC | 10% Owner | Buy | $7K (1,754 @ $4.15) |
| May 19, 2014 | Orion Holdings V, LLC | 10% Owner | Buy | $7K (1,754 @ $4.15) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.